206
Views
0
CrossRef citations to date
0
Altmetric
Review

Congenital hypothyroidism: current perspectives

&
Pages 91-102 | Published online: 17 Jul 2015

References

  • Centers for Disease Control and Prevention (CDC). Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment – United States, 2003. MMWR Morb Mortal Wkly Rep. 2004;53(3):57–59.
  • Grosse SD, Van Vliet G. Prevention of intellectual disability through screening for congenital hypothyroidism: how much and at what level? Arch Dis Child. 2011;96(4):374–379.
  • Van Vliet G, Grosse SD. The continuing health burden of congenital hypothyroidism in the era of neonatal screening. J Clin Endocrinol Metab. 2011;96(6):1671–1673.
  • Alm J, Larsson A, Zetterström R. Congenital hypothyroidism in Sweden. Incidence and age at diagnosis. Acta Paediatr Scand. 1978;67(1):1–3.
  • Klett M. Epidemiology of congenital hypothyroidism. Exp Clin Endocrinol Diabetes. 1997;105(Suppl 4):19–23.
  • Prabhu SR, Mahadevan S, Jagadeesh S, Suresh S. Congenital hypothyroidism: recent Indian data. Indian J Endocrinol Metab. 2015;19:436–437.
  • Sareen N, Pradhan R. Need for neonatal screening program in India: a national priority. Indian J Endocrinol Metab. 2015;19(2):204–220.
  • Hinton CF, Harris KB, Borgfeld L, et al. Trends in incidence rates of congenital hypothyroidism related to select demographic factors: data from the United States, California, Massachusetts, New York, and Texas. Pediatrics. 2010;125(Suppl 2):S37–S47.
  • Botler J, Camacho LA, Cruz MM. Phenylketonuria, congenital hypothyroidism and haemoglobinopathies: public health issues for a Brazilian newborn screening program. Cad Saude Publica. 2012;28(9):1623–1631.
  • Skordis N, Toumba M, Savva SC, et al. High prevalence of congenital hypothyroidism in the Greek Cypriot population: results of the neonatal screening program 1990–2000. J Pediatr Endocrinol Metab. 2005;18(5):453–461.
  • Gaudino R, Garel C, Czernichow P, Léger J. Proportion of various types of thyroid disorders among newborns with congenital hypothyroidism and normally located gland: a regional cohort study. Clin Endocrinol (Oxf). 2005;62(4):444–448.
  • Hill MA. Embryology Endocrine – Thyroid Development. 2015, Available from: https://embryology.med.unsw.edu.au/embryology/index.php/Endocrine_-_Thyroid_Development. Accessed April 1, 2015.
  • Park S, Chatterjee V. Genetics of congenital hypothyroidism. J Med Genet. 2005;42:379–389.
  • Lania G, Zhang Z, Huynh T, et al. Early thyroid development requires a Tbx1-Fgf8 pathway. Dev Biol. 2009;328(1):109–117.
  • Stenzel D, Huttner WB. Role of maternal thyroid hormones in the developing neocortex and during human evolution. Front Neuroanat. 2013;7:19.
  • Rastogi MV, LaFranchi SH. Congenital hypothyroidism. Orphanet J Rare Dis. 2010;5:17.
  • Dias VM, Campos AP, Chagas AJ, Silva RM. Congenital hypothyroidism: etiology. J Pediatr Endocrinol Metab. 2010;23(8):815–826.
  • Sindhuja L, Dayal D, Sodhi KS, Sachdeva N, Bhattacharya A. Thyroid dysfunction and developmental anomalies in first degree relatives of children with thyroid dysgenesis: data from a developing country. World J Pediatr. In press 2015.
  • Narumi S, Muroya K, Asakura Y, Adachi M, Hasegawa T. Transcription factor mutations and congenital hypothyroidism: systematic genetic screening of a population-based cohort of Japanese patients. J Clin Endocrinol Metab. 2010;95:1981–1985.
  • Eugène D, Djemli A, Van Vliet G. Sexual dimorphism of thyroid function in newborns: with congenital hypothyroidism. J Clin Endocrinol Metab. 2005;90:2696–2700.
  • Dayal D, Sindhuja L, Bhattacharya A, Bharti B. Advanced maternal age in Indian children with thyroid dysgenesis. Clin Pediatr Endocrinol. 2015;24(2):59–62.
  • Kirmizibekmez H, Güven A, Yildiz M, Cebeci AN, Dursun F. Developmental defects of the thyroid gland: relationship with advanced maternal age. J Clin Res Pediatr Endocrinol. 2012;4(2):72–75.
  • Hashemipour M, Ghasemi M, Hovsepian S, et al. Etiology of congenital hypothyroidism in Isfahan: Does it different? Adv Biomed Res. 2014;3:21.
  • Dayal D, Sindhuja L, Bhattacharya A, Sodhi KS, Sachdeva N. Agenesis and not ectopia is common in North Indian children with thyroid dysgenesis. Indian J Endocrinol Metab. 2014;18(Suppl S1):97–99.
  • Guerra G, Cinelli M, Mesolella M, et al. Morphological, diagnostic and surgical features of ectopic thyroid gland: a review of literature. Int J Surg. 2014;12(Suppl 1):S3–S11.
  • Perry RJ, Maroo S, Maclennan AC, Jones JH, Donaldson MD. Combined ultrasound and isotope scanning is more informative in the diagnosis of congenital hypothyroidism than single scanning. Arch Dis Child. 2006;91:972–976.
  • Djemli A, Fillion M, Belgoudi J, et al. Twenty years later: a reevaluation of the contribution of plasma thyroglobulin to the diagnosis of thyroid dysgenesis in infants with congenital hypothyroidism. Clin Biochem. 2004;37(9):818–822.
  • Grasberger H, Refetoff S. Genetic causes of congenital hypothyroidism due to dyshormonogenesis. Curr Opin Pediatr. 2011;23(4):421–428.
  • Abramowicz MJ, Targovnik HM, Varela V, et al. Identification of a mutation in the coding sequence of the human thyroid peroxidase gene causing congenital goiter. J Clin Invest. 1992;90(4):1200–1204.
  • Fugazzola L, Cerutti N, Mannavola D, et al. Monoallelic expression of mutant thyroid peroxidase allele causing total iodide organification defect. J Clin Endocrinol Metab. 2003;88(7):3264–3271.
  • Moreno JC, Bikker H, Kempers MJ, et al. Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N Engl J Med. 2002;347(2):95–102.
  • Hulur I, Hermanns P, Nestoris C, et al. A single copy of the recently identified dual oxidase maturation factor (DUOXA) 1 gene produces only mild transient hypothyroidism in a patient with a novel biallelic DUOXA2 mutation and monoallelic DUOXA1 deletion. J Clin Endocrinol Metab. 2011;96(5):E841–E845.
  • Everett LA, Glaser B, Beck JC, et al. Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet. 1997;17(4):411–422.
  • Ieiri T, Cochaux P, Targovnik HM, et al. A 3′ splice site mutation in the thyroglobulin gene responsible for congenital goiter with hypothyroidism. J Clin Invest. 1991;88(6):1901–1905.
  • Spitzweg C, Morris JC. Genetics and phenomics of hypothyroidism and goiter due to NIS mutations. Mol Cell Endocrinol. 2010;322(1–2):56–63.
  • Narumi S, Hasegawa T. TSH resistance revisited (review). Endocr J. 2015;62(5):393–398.
  • Gupta V, Lee M. Central hypothyroidism. Indian J Endocrinol Metab. 2011;15(Suppl 2):S99–S106.
  • Friesema EC, Jansen J, Heuer H, Trajkovic M, Bauer K, Visser TJ. Mechanisms of disease: psychomotor retardation and high T3 levels caused by mutations in monocarboxylate transporter 8. Nat Clin Pract Endocrinol Metab. 2006;2(9):512–523.
  • Olateju TO, Vanderpump MP. Thyroid hormone resistance. Ann Clin Biochem. 2006;43(Pt 6):431–440.
  • Parks JS, Lin M, Grosse SD, et al. The impact of transient hypothyroidism on the increasing rate of congenital hypothyroidism in the United States. Pediatrics. 2010;125(Suppl 2):S54–S63.
  • Oren A, Wang MK, Brnjac L, Mahmud FH, Palmert MR. Mild neonatal hyperthyrotrophinaemia: 10-year experience suggests the condition is increasingly common but often transient. Clin Endocrinol (Oxf). 2013;79(6):832–837.
  • Bhavani N. Transient congenital hypothyroidism. Indian J Endocrinol Metab. 2011;15(Suppl 2):S117–S120.
  • Yang RL, Zhu ZW, Zhou XL, Zhao ZY. Treatment and follow-up of children with transient congenital hypothyroidism. J Zhejiang Univ Sci B. 2005;6(12):1206–1209.
  • Matsuura N, Yamada Y, Nohara Y, et al. Familial neonatal transient hypothyroidism due to maternal TSH-binding inhibitor immunoglobulins. N Engl J Med. 1980;303(13):738–741.
  • Li C, Cheng Y, Tang Q, et al. The association between prenatal exposure to organochlorine pesticides and thyroid hormone levels in newborns in Yancheng, China. Environ Res. 2014;129:47–51.
  • Zung A, Tenenbaum-Rakover Y, Barkan S, et al. Neonatal hyperthyrotropinemia: population characteristics, diagnosis, management and outcome after cessation of therapy. Clin Endocrinol (Oxf). 2010;72:264–271.
  • Papendieck P, Chiesa A, Prieto L, Gruñeiro-Papendieck L. Thyroid disorders of neonates born to mothers with Graves’ disease. J Pediatr Endocrinol Metab. 2009;22(6):547–553.
  • Bessho K, Etani Y, Ichimori H, et al. Increased type 3 iodothyronine deiodinase activity in a regrown hepatic hemangioma with consumptive hypothyroidism. Eur J Pediatr. 2010;169(2):215–221.
  • Peters C, Langham S, Mullis PE, Dattani MT. Use of combined liothyronine and thyroxine therapy for consumptive hypothyroidism associated with hepatic haemangiomas in infancy. Horm Res Paediatr. 2010;74(2):149–152.
  • Rabbiosi S, Vigone MC, Cortinovis F, et al. Congenital hypothyroidism with eutopic thyroid gland: analysis of clinical and biochemical features at diagnosis and after re-evaluation. J Clin Endocrinol Metab. 2013;98(4):1395–1402.
  • Cho MS, Cho GS, Park SH, Jung MH, Suh BK, Koh DG. Earlier re-evaluation may be possible in pediatric patients with eutopic congenital hypothyroidism requiring lower L-thyroxine doses. Ann Pediatr Endocrinol Metab. 2014;19(3):141–145.
  • Farwell AP. Nonthyroidal illness syndrome. Curr Opin Endocrinol Diabetes Obes. 2013;20(5):478–484.
  • Vigone MC, Caiulo S, Di Frenna M, et al. Evolution of thyroid function in preterm infants detected by screening for congenital hypothyroidism. J Pediatr. 2014;164(6):1296–1302.
  • King K, O’Gorman C, Gallagher S. Thyroid dysfunction in children with Down syndrome: a literature review. Ir J Med Sci. 2014;183(1):1–6.
  • Dayal D, Jain P, Panigrahi I, Bhattacharya A, Sachdeva N. Thyroid dysfunction in Indian children with Down syndrome. Indian Pediatr. 2014;51(9):751–752.
  • Cebeci AN, Güven A, Yildiz M. Profile of hypothyroidism in Down’s syndrome. J Clin Res Pediatr Endocrinol. 2013;5(2):116–120.
  • Bull MJ; Committee on Genetics. Health supervision for children with Down syndrome. Pediatrics. 2011;128(2):393–406.
  • van Trotsenburg AS, Vulsma T, van Rozenburg-Marres SL, et al. The effect of thyroxine treatment started in the neonatal period on development and growth of two-year-old Down syndrome children: a randomized clinical trial. J Clin Endocrinol Metab. 2005;90(6):3304–3311.
  • Kowalczyk K, PukajŁo K, Malczewska A, Król-Chwastek A, Barg E. L-thyroxine therapy and growth processes in children with Down syndrome. Adv Clin Exp Med. 2013;22(1):85–92.
  • Gagné N, Parma J, Deal C, Vassart G, Van Vliet G. Apparent congenital athyreosis contrasting with normal plasma thyroglobulin levels and associated with inactivating mutations in the thyrotropin receptor gene: are athyreosis and ectopic thyroid distinct entities? J Clin Endocrinol Metab. 1998;83(5):1771–1775.
  • Castanet M, Polak M, Bonaïti-Pellié C, Lyonnet S, Czernichow P, Léger J. Nineteen years of national screening for congenital hypothyroidism: familial cases with thyroid dysgenesis suggest the involvement of genetic factors. J Clin Endocrinol Metab. 2001;86(5):2009–2014.
  • Léger J, Marinovic D, Garel C, Bonaïti-Pellié C, Polak M, Czernichow P. Thyroid developmental anomalies in first degree relatives of children with congenital hypothyroidism. J Clin Endocrinol Metab. 2002;87(2):575–580.
  • Nandi-Munshi D, Taplin CE. Thyroid-related neurological disorders and complications in children. Pediatr Neurol. 2015;52(4):373–382.
  • Tashko V, Davachi F, Baboci R, Drishti G, Hoxha P. Kocher-Debré Sémélaigne syndrome. Clin Pediatr (Phila). 1999;38(2):113–115.
  • Asami T, Kikuchi T, Kamimura T, Kinoshita S, Uchiyama M. Precocious puberty in a girl with congenital hypothyroidism receiving continuous L-thyroxine-replacement therapy. Pediatr Int. 2001;43(1):87–90.
  • Sharma D, Dayal D, Gupta A, Saxena A. Premature menarche associated with primary hypothyroidism in a 5.5-year-old girl. Case Rep Endocrinol. 2011;2011:678305.
  • Dayal D, Bhalla AK, Sachdeva N. A boy with prepubertal gynecomastia, hyperprolactinemia, and hypothyroidism. J Pediatr Endocr Metab 2013;26(3–4):357–360.
  • Sukumar SP, Balachandran K, Jayakumar, et al. Congenital hypothyroidism – an usual suspect at an unusual age: a case series. Indian J Endocrinol Metab. 2013;17(Suppl 1):S184–S187.
  • Kreisner E, Neto EC, Gross JL. High prevalence of extrathyroid malformations in a cohort of Brazilian patients with permanent primary congenital hypothyroidism. Thyroid. 2005;15(2):165–169.
  • Kumar J, Gordillo R, Kaskel FJ, Druschel CM, Woroniecki RP. Increased prevalence of renal and urinary tract anomalies in children with congenital hypothyroidism. J Pediatr. 2009;154(2):263–266.
  • Reddy PA, Rajagopal G, Harinarayan CV, et al. High prevalence of associated birth defects in congenital hypothyroidism. Int J Pediatr Endocrinol. 2010;2010:940980.
  • Dentice M, Cordeddu V, Rosica A, et al. Missense mutation in the transcription factor NKX2-5: a novel molecular event in the pathogenesis of thyroid dysgenesis. J Clin Endocrinol Metab. 2006;91(4):1428–1433.
  • Thomas PQ, Brown A, Beddington RS. Hex: a homeobox gene revealing peri-implantation asymmetry in the mouse embryo and an early transient marker of endothelial cell precursors. Development. 1998;125(1):85–94.
  • Soh LM, Druce M, Grossman AB, et al. Evaluation of genotype-phenotype relationships in patients referred for endocrine assessment in suspected Pendred syndrome. Eur J Endocrinol. 2015;172(2):217–226.
  • Kara C, Kiliç M, Uçaktürk A, Aydin M. Congenital goitrous hypothyroidism, deafness and iodide organification defect in four siblings: Pendred or pseudo-Pendred syndrome? J Clin Res Pediatr Endocrinol. 2010;2(2):81–84.
  • Pfarr N, Borck G, Turk A, et al. Goitrous congenital hypothyroidism and hearing impairment associated with mutations in the TPO and SLC26A4/PDS genes. J Clin Endocrinol Metab. 2006;91(7):2678–2681.
  • Clifton-Bligh RJ, Wentworth JM, Heinz P, et al. Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia. Nat Genet. 1998;19(4):399–401.
  • Ferrara AM, De Michele G, Salvatore E, et al. A novel NKX2.1 mutation in a family with hypothyroidism and benign hereditary chorea. Thyroid. 2008;18(9):1005–1009.
  • Rezaei N, Sabbaghian M, Liu Z, Zenker M. Eponym: Johanson–Blizzard syndrome. Eur J Pediatr. 2011;170(2):179–183.
  • Torresani T. Neonatal screening for congenital hypothyroidism. Endocr Dev. 2014;26:44–49.
  • Léger J, Olivieri A, Donaldson M, et al; ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE; Congenital Hypothyroidism Consensus Conference Group. European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. J Clin Endocrinol Metab. 2014;99(2):363–384.
  • Clerc J. Imaging the thyroid in children. Best Pract Res Clin Endocrinol Metab. 2014;28(2):203–220.
  • Clerc J, Monpeyssen H, Chevalier A, et al. Scintigraphic imaging of paediatric thyroid dysfunction. Horm Res. 2008;70(1):1–13.
  • Fugazzola L, Persani L, Vannucchi G, et al. Thyroid scintigraphy and perchlorate test after recombinant human TSH: a new tool for the differential diagnosis of congenital hypothyroidism during infancy. Eur J Nucl Med Mol Imaging. 2007;34(9):1498–1503.
  • Selva KA, Mandel SH, Rien L, et al. Initial treatment dose of L-thyroxine in congenital hypothyroidism. J Pediatr. 2002;141(6):786–792.
  • Peroni E, Vigone MC, Mora S, et al. Congenital hypothyroidism treatment in infants: a comparative study between liquid and tablet formulations of levothyroxine. Horm Res Paediatr. 2014;81(1):50–54.
  • Liwanpo L, Hershman JM. Conditions and drugs interfering with thyroxine absorption. Best Pract Res Clin Endocrinol Metab. 2009;23(6):781–792.
  • LaFranchi SH, Austin J. How should we be treating children with congenital hypothyroidism? J Pediatr Endocrinol Metab. 2007;20(5):559–578.
  • Selva KA, Harper A, Downs A, Blasco PA, Lafranchi SH. Neurodevelopmental outcomes in congenital hypothyroidism: comparison of initial T4 dose and time to reach target T4 and TSH. J Pediatr. 2005;147(6):775–780.
  • Bakker B, Kempers MJ, De Vijlder JJ, et al. Dynamics of the plasma concentrations of TSH, FT4 and T3 following thyroxine supplementation in congenital hypothyroidism. Clin Endocrinol (Oxf). 2002;57(4):529–537.
  • Heyerdahl S, Oerbeck B. Congenital hypothyroidism: developmental outcome in relation to levothyroxine treatment variables. Thyroid. 2003;13(11):1029–1038.
  • Rovet JF, Ehrlich RM. Long-term effects of L-thyroxine therapy for congenital hypothyroidism. J Pediatr. 1995;126(3):380–386.
  • Dayal D, Saini L, Attri SV, Singh B, Bhalla AK. Daily versus alternate day thyroxine therapy to maintain euthyroidism in children with congenital hypothyroidism. Int J Endocrinol Metab. 2013;11(4):e9499.
  • Albert BB, Heather N, Derraik JG, et al. Neurodevelopmental and body composition outcomes in children with congenital hypothyroidism treated with high-dose initial replacement and close monitoring. J Clin Endocrinol Metab. 2013;98(9):3663–3670.
  • van der Sluijs Veer L, Kempers MJ, Wiedijk BM, Last BF, Grootenhuis MA, Vulsma T. Evaluation of cognitive and motor development in toddlers with congenital hypothyroidism diagnosed by neonatal screening. J Dev Behav Pediatr. 2012;33(8):633–640.
  • Donaldson M, Jones J. Optimising outcome in congenital hypothyroidism; current opinions on best practice in initial assessment and subsequent management. J Clin Res Pediatr Endocrinol. 2013;5(Suppl 1):13–22.
  • Léger J. Congenital hypothyroidism: a clinical update of long-term outcome in young adults. Eur J Endocrinol. 2015;172(2):R67–R77.